Product Name | GRF (human) Acetate | Sequence | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2 | Cas No. | 83930-13-6 | Molecular Formula | C215H358N72O66S | Molecular Weight | 5039.76 | Purity (HPLC) | 98.0%min. | Appearance | White powder | Single Impurity (HPLC) | 1.0%max | Amino Acid Composition | ±10% of theoretical | Peptide Content (N%) | 80.0% | Water Content(Karl Fischer) | 10.0% | Acetate Content (HPIC) | 15.0% | MS(ESI) | Consistent | Mass Balance | 95.0~105.0% | | | |
|
|
With more than 20 years of experience in solid-phase peptide synthesis, SBS Genetech is recognized as one of the global major leading industry players in Peptide Synthesis by third-party market researchers. For more details, please visit Peptide Synthesis Market 2017-2022 International Outlook, Trends and Analysis.
Only for research and not intended for treatment of humans or animals
